BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanh DT, Mekata E, Mukaisho K, Sugihara H, Shimizu T, Shiomi H, Murata S, Naka S, Yamamoto H, Endo Y, Tani T. Prognostic role of CD10+ myeloid cells in association with tumor budding at the invasion front of colorectal cancer. Cancer Science 2011;102:1724-33. [DOI: 10.1111/j.1349-7006.2011.01987.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Marangon Junior H, Rocha VN, Leite CF, de Aguiar MCF, Souza PEA, Horta MCR. Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med 2014;43:199-204. [DOI: 10.1111/jop.12121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
2 Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol 2019;16:601-20. [DOI: 10.1038/s41571-019-0222-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 179] [Article Influence: 54.3] [Reference Citation Analysis]
3 Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY, Ahn JY, Broaddus RR, Taketo MM, Lydon JP, Leach RE, Lessey BA, Fazleabas AT, Lim JM, Jeong JW. β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J Pathol 2013;231:210-22. [PMID: 23784889 DOI: 10.1002/path.4224] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
4 Bui TM, Yalom LK, Sumagin R. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance. Expert Opin Ther Targets 2021;25:573-83. [PMID: 34236924 DOI: 10.1080/14728222.2021.1954162] [Reference Citation Analysis]
5 Brunner SM, Kesselring R, Rubner C, Martin M, Jeiter T, Boerner T, Ruemmele P, Schlitt HJ, Fichtner-Feigl S. Prognosis according to histochemical analysis of liver metastases removed at liver resection. Br J Surg. 2014;101:1681-1691. [PMID: 25331841 DOI: 10.1002/bjs.9627] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
6 Jang TJ, Park JB, Lee JI. The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development. Korean J Pathol 2013;47:340-7. [PMID: 24009629 DOI: 10.4132/KoreanJPathol.2013.47.4.340] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen XL, Chen ZQ, Zhu SL, Liu TW, Wen Y, Su YS, Xi XJ, Hu Y, Lian L, Liu FB. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer 2017;17:240. [PMID: 28376764 DOI: 10.1186/s12885-017-3215-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
8 Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787-820. [PMID: 34074695 DOI: 10.1101/gad.348226.120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kadota K, Villena-Vargas J, Nitadori J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma. Ann Surg Oncol 2015;22:3136-43. [PMID: 25608772 DOI: 10.1245/s10434-015-4374-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Huang X, He C, Lin G, Lu L, Xing K, Hua X, Sun S, Mao Y, Song Y, Wang J, Li S. Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun 2020;524:1064-71. [PMID: 32070494 DOI: 10.1016/j.bbrc.2020.02.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Lecot P, Sarabi M, Pereira Abrantes M, Mussard J, Koenderman L, Caux C, Bendriss-Vermare N, Michallet MC. Neutrophil Heterogeneity in Cancer: From Biology to Therapies. Front Immunol 2019;10:2155. [PMID: 31616408 DOI: 10.3389/fimmu.2019.02155] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 18.3] [Reference Citation Analysis]
12 Elliott LA, Doherty GA, Sheahan K, Ryan EJ. Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity. Front Immunol. 2017;8:86. [PMID: 28220123 DOI: 10.3389/fimmu.2017.00086] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 20.4] [Reference Citation Analysis]
13 Kadota K, Buitrago D, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer 2015;89:329-36. [PMID: 26141216 DOI: 10.1016/j.lungcan.2015.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract. 2015;211:557-569. [PMID: 26092594 DOI: 10.1016/j.prp.2015.05.010] [Cited by in Crossref: 164] [Cited by in F6Publishing: 177] [Article Influence: 23.4] [Reference Citation Analysis]
15 Khanh do T, Mekata E, Mukaisho K, Sugihara H, Shimizu T, Shiomi H, Murata S, Naka S, Yamamoto H, Endo Y, Tani T. Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer. Cancer Sci 2013;104:958-64. [PMID: 23566254 DOI: 10.1111/cas.12170] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
16 Lino-Silva LS, Salcedo-Hernández RA, Gamboa-Domínguez A. Tumour budding in rectal cancer. A comprehensive review. Contemp Oncol (Pozn) 2018;22:61-74. [PMID: 30150882 DOI: 10.5114/wo.2018.77043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Mizutani N, Abe M, Kajino K, Matsuoka S. A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma. Monoclon Antib Immunodiagn Immunother 2021;40:21-7. [PMID: 33625287 DOI: 10.1089/mab.2020.0033] [Reference Citation Analysis]
18 Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG. TGF-beta signalling in colon carcinogenesis. Cancer Lett. 2012;314:1-7. [PMID: 22018778 DOI: 10.1016/j.canlet.2011.09.041] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
19 Kadota K, Nitadori JI, Ujiie H, Buitrago DH, Woo KM, Sima CS, Travis WD, Jones DR, Adusumilli PS. Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor. J Thorac Oncol 2015;10:1301-10. [PMID: 26291010 DOI: 10.1097/JTO.0000000000000617] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
20 Kodama H, Murata S, Ishida M, Yamamoto H, Yamaguchi T, Kaida S, Miyake T, Takebayashi K, Kushima R, Tani M. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer. Br J Cancer 2017;116:186-94. [PMID: 27931044 DOI: 10.1038/bjc.2016.401] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
21 Vo TN, Mekata E, Umeda T, Abe H, Kawai Y, Mori T, Kubota Y, Shiomi H, Naka S, Shimizu T, Murata S, Yamamoto H, Ishida M, Tani T. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma. Breast Cancer 2015;22:117-28. [PMID: 23575921 DOI: 10.1007/s12282-013-0459-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]